Literature DB >> 29483768

Hybrid Strategy for High-Risk Neonates with Interrupted Aortic Arch: A Can Well Worth Kicking?

Eva Kapravelou1, David Anderson1, Gareth J Morgan1.   

Abstract

The use of hybrid techniques to avoid neonatal cardiopulmonary bypass in high-risk individuals is well reported in the setting of hypoplastic left heart syndrome. We describe the use of that technique as a bridging procedure in high-risk neonates with an interrupted aortic arch. We report three cases where hybrid branch pulmonary artery banding and ductal stent implantation has been successfully used to defer complete repair, allowing recovery, maturity, and weight gain. This strategy may be considered for patients deemed at high risk for primary neonatal repair.

Entities:  

Keywords:  hybrid procedure; interrupted aortic arch; low birth weight

Year:  2017        PMID: 29483768      PMCID: PMC5825225          DOI: 10.1055/s-0037-1602374

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  17 in total

Review 1.  Management of Interrupted Aortic Arch.

Authors:  Richard A Jonas
Journal:  Semin Thorac Cardiovasc Surg       Date:  2015-06-14

2.  Analysis of preoperative condition and interstage mortality in Norwood and hybrid procedures for hypoplastic left heart syndrome using the Aristotle scoring system.

Authors:  David F A Lloyd; Lindsay Cutler; Shane M Tibby; Sunitha Vimalesvaran; Shakeel Ahmed Qureshi; Eric Rosenthal; David Anderson; Conal Austin; Hannah Bellsham-Revell; Thomas Krasemann
Journal:  Heart       Date:  2014-01-10       Impact factor: 5.994

3.  Hybrid palliation of interrupted aortic arch in a high-risk neonate.

Authors:  Mohsen Karimi; Ahmed Farouk; Alex Golden; Robert Gilkeson
Journal:  Ann Pediatr Cardiol       Date:  2010-01

4.  Two-year neurodevelopmental outcomes of infants undergoing neonatal cardiac surgery for interrupted aortic arch: a descriptive analysis.

Authors:  Chloe A Joynt; Charlene M T Robertson; Po-Yin Cheung; Alberto Nettel-Aguirre; Ari R Joffe; Reg S Sauve; Wayne S G Biggs; Norma J Leonard; David B Ross; Ivan M Rebeyka
Journal:  J Thorac Cardiovasc Surg       Date:  2009-06-23       Impact factor: 5.209

5.  Determinants of survival following repair of interrupted aortic arch in infancy.

Authors:  S A Qureshi; B Maruszewski; R McKay; R Arnold; C A West; D I Hamilton
Journal:  Int J Cardiol       Date:  1990-03       Impact factor: 4.164

6.  Twenty-three years of single-stage end-to-side anastomosis repair of interrupted aortic arches.

Authors:  Aisyah Hussein; Ajay J Iyengar; Bryn Jones; Susan M Donath; Igor E Konstantinov; Leeanne E Grigg; Gavin Wheaton; Andrew Bullock; Christian P Brizard; Yves d'Udekem
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04       Impact factor: 5.209

7.  Timing of presentation and postnatal outcome of infants suspected of having coarctation of the aorta during fetal life.

Authors:  C E G Head; V C Jowett; G K Sharland; J M Simpson
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

8.  Outcomes of interrupted aortic arch repair using the carotid artery turndown procedure.

Authors:  Steven H Todman; Osama Eltayeb; Mark Ruzmetov; Mark D Rodefeld; Mark W Turrentine; John W Brown; John P Breinholt
Journal:  J Thorac Cardiovasc Surg       Date:  2012-10-06       Impact factor: 5.209

9.  Extended Application of the Hybrid Procedure in Neonates with Left-Sided Obstructive Lesions in an Evolving Cardiac Program.

Authors:  Anas Taqatqa; Karim A Diab; Christopher Stuart; Louis Fogg; Michel Ilbawi; Sawsan Awad; Massimo Caputo; Zahid Amin; Ra-Id Abdulla; Damien Kenny; Ziyad M Hijazi
Journal:  Pediatr Cardiol       Date:  2015-11-04       Impact factor: 1.655

10.  Fifteen-year single center experience with the "Giessen Hybrid" approach for hypoplastic left heart and variants: current strategies and outcomes.

Authors:  Dietmar Schranz; Anna Bauer; Bettina Reich; Blanka Steinbrenner; Sabine Recla; Dorle Schmidt; Christian Apitz; Josef Thul; Klaus Valeske; Jürgen Bauer; Matthias Müller; Christian Jux; Ina Michel-Behnke; Hakan Akintürk
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.